T R Fleming
Overview
Explore the profile of T R Fleming including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
4155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Odem-Davis K, Fleming T
Stat Biopharm Res
. 2015 Jun;
7(1):12-24.
PMID: 26052374
In non-inferiority trials, acceptable efficacy of an experimental treatment is established by ruling out some defined level of reduced effect relative to an effective active control standard. Serial use of...
2.
POWERS J, Fleming T
Clin Pharmacol Ther
. 2009 Aug;
86(3):244-7.
PMID: 19707216
Given the changing epidemiology of disease due to Staphylococcus aureus (SA), including the emergence of drug-resistant organisms such as methicillin-resistant SA, investigators may wish to evaluate the effects of antimicrobials...
3.
Petkau J, Reingold S, Held U, Cutter G, Fleming T, Hughes M, et al.
Mult Scler
. 2008 Jun;
14(6):770-8.
PMID: 18535021
Background: Magnetic resonance imaging (MRI) of lesions in the brain may be the best current candidate for a surrogate biological marker of clinical outcomes in relapsing remitting multiple sclerosis (MS),...
4.
Fleming T
Ann N Y Acad Sci
. 2000 Dec;
918:201-11.
PMID: 11131706
Efficient approaches are needed for obtaining reliable insights into the safety, in developing and developed country settings, of interventions for prevention of mother-to-child transmission (MCT) of HIV. A randomized trial...
5.
Fleming T, Lin D
Biometrics
. 2000 Dec;
56(4):971-83.
PMID: 11129494
The field of survival analysis emerged in the 20th century and experienced tremendous growth during the latter half of the century. The developments in this field that have had the...
6.
7.
8.
Tabet S, Surawicz C, Horton S, Paradise M, Coletti A, Gross M, et al.
Sex Transm Dis
. 1999 Nov;
26(10):564-71.
PMID: 10560720
Background And Objectives: Methods of HIV and STD prevention, which can be controlled by the receptive partner, are a high priority for research and development. Studies on the safety of...
9.
Fleming T
Semin Oncol
. 1999 Sep;
26(4 Suppl 12):102-7.
PMID: 10482201
A guiding objective of phase III clinical trials should be to achieve reliable evaluation of safety and efficacy of interventions in a real-world setting, ie, as the interventions would be...
10.
Psaty B, Weiss N, Furberg C, Koepsell T, Siscovick D, Rosendaal F, et al.
JAMA
. 1999 Aug;
282(8):786-90.
PMID: 10463718
No abstract available.